Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus Using Regadenoson Stress Cardiac Magnetic Resonance Imaging

NCT00797186 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT00797186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00797186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus Using Regadenoson Stress Cardiac Magnetic Resonance Imaging
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2008
Completion date
December 31, 2011
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microvascular dysfunction, type 2 diabetes